Nucleo offers an AI-powered tool for analyzing body composition and segmenting tumors from medical images.
Nucleo has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2025.
Nucleo's investors include Y Combinator.
Nucleo is headquartered in San Francisco, United States.
Nucleo offers an AI-powered tool for analyzing body composition and segmenting tumors from medical images.
Nucleo is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nucleo — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/nucleo-san-francisco. Accessed August 1, 2026.
VCBacked. (2025). Nucleo — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/nucleo-san-francisco
{{cite web |title=Nucleo — Funding & Investors |url=https://www.vcbacked.co/company/nucleo-san-francisco |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated